Damon Broyles

Vice President, Clinical Innovation, Mercy Technology Services

Dr. Damon Broyles currently has the privilege of serving as VP, Clinical Innovation for Mercy Technology Services, the technical support arm of Mercy Healthcare. Mercy is a $6B healthcare organization headquartered in St. Louis, MO and the 5th largest Catholic Health system in the US. It encompasses 40+ hospitals, 800 physician practices and outpatient facilities, 3,200 integrated providers and 44,000 coworkers. Mercy is a Top 5 best performing large healthcare system as noted by Truven for multiple years running, and MTS has been critical in garnering the HIMSS Davies Award, CHiME Most Wired, and numerous HIMSS stage 7 hospital designations, amongst others. Dr. Broyles is a board-certified diplomate and fellow with the American Board of Family Medicine and holds a subspecialty certification in Clinical Informatics from the American Board of Preventive Medicine. He trained at the University of Missouri, Columbia and completed a chief residency at Mercy St. Louis hospital in 2004. Currently his role comprises two core fundamental activities - the first being optimization of the Mercy’s enterprise EHR platform to achieve an ideal provider, patient & health system experience in pursuit of high quality outcomes. Second, Dr. Broyles leads efforts to source, synthesize and integrate new and state of the science technologies into the larger Mercy health system strategy. In pursuit of this second goal, he has developed deep relationships with the accelerator and tech startup landscape in the region and beyond. He has served as an entrepreneurial and health IT mentor at Sling Health – a biotech and healthcare incubator with roots at Washington University. As well, he volunteers and coaches in a similar capacity with the UM system EQ accelerator based at UMSL. He participates on the Community of Health Innovation Leaders for the GlobalSTL initiative and serves on the Missouri Biotechnology Board of Directors. In addition, he represents Mercy’s interests on the Ascension Ventures CHV fund. Dr. Broyles holds a profound dedication to advancing the health of patients and communities via the use of creative and ingenious applications of novel solutions. In addition, he co-founded Where4.Care – a chatbot based mobile application utilizing natural language processing with the aim of reducing unnecessary ER utilization. Beyond that, Dr. Broyles has a diverse and experienced background in many other areas of value-based care. Under his tenure on the St.